<p>The invention provides HSV antigens that are useful for the prevention and treatment of HSV infection. Disclosed herein are epitopes confirmed to be recognized by T-cells derived from herpetic lesions. T-cells having specificity for antigens of the invention have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against cells infected with HSV. The identification of immunogenic antigens responsible for T-cell specificity provides improved anti-viral therapeutic and prophylactic strategies. Compositions containing antigens or polynucleotides encoding antigens of the invention provide effectively targeted vaccines for prevention and treatment of HSV infection.</p>
申请公布号
EP1222281(A2)
申请公布日期
2002.07.17
申请号
EP20000968457
申请日期
2000.09.28
申请人
UNIVERSITY OF WASHINGTON;CORIXA CORPORATION;FRED HUTCHINSON CANCER RESEARCH CENTER